Jeffrey LaRose, Chief Scientific Officer at HeartWare International, Inc. (HTWR), sold 560 shares at $36.94 ($20K) on 2016-02-08, disclosed to the SEC on 2016-02-09.
Scheduled sale ($20k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.76 | 160 | $6K | 27.2% |
| 2 | $36.94 | 300 | $11K | 54.2% |
| 3 | $38.12 | 100 | $4K | 18.6% |
| Total | $36.53 avg | 560 | $20K | 100% |
| Filing → |
| HTWR | SELL | 2015-12-23 | $57K | — | Filing → |
| HTWR | SELL | 2015-02-26 | $30K | — | Filing → |
| HTWR | SELL | 2015-02-10 | $42K | — | Filing → |